GLD vs XBI
SPDR Gold Shares vs SPDR S&P Biotech ETF
GLD—
SPDR Gold Shares
Physically backed gold ETF.
Expense: —Yield: —
XBI—
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: —Yield: —
Side-by-side metrics
| Metric | GLD | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | State Street | State Street |
GLD top holdings
Holdings data unavailable for GLD.
XBI top holdings
Holdings data unavailable for XBI.
About GLD
GLD (SPDR Gold Shares) is Physically backed gold ETF.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index.